A Poor Outcome after Inappropriate Use of an Over-the-Counter Fetal Listening Device

References

1. ↵
   Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self medication. Drug Saf 2001; 24: 1027–3.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF. Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol 1991; 26: 174–8.

   OpenUrlPubMedWeb of Science
3. ↵
   Unintentional acetaminophen hepatotoxicity. Washington DC: Nonprescription Drugs Advisory Committee, Food and Drug Administration; 2002. Available at: URL: http://www.fda.gov/ohrms/dockets/ac/02/transcripts/3882T1.htm
4. ↵
   Ahn MO, Phelan JP, Smith CV, Jacobs N, Rutherford SE. Antepartum fetal surveillance in the patient with decreased fetal movement. Am J Obstet Gynecol 1987; 157: 860–4.

   OpenUrlPubMed
5. ↵
   Harrington K, Thompson O, Jordan L, Page J, Carpenter RG, Campbell S. Obstetric outcome in women who present with a reduction in fetal movements in the third trimester of pregnancy. J Perinat Med 1998; 26: 77–8.

   OpenUrlPubMed
6. ↵
   Grant A, Elbourne D, Valentin L, Alexander A. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet 1989; 2: 345–34.

   OpenUrlPubMedWeb of Science